Lista de obras - Nuno Miguel Pires - Dominio Público Uruguay

Activation of nuclear receptor Nur77 by 6-mercaptopurine protects against neointima formation.

artículo científico publicado en 2007

Apolipoprotein C-I is crucially involved in lipopolysaccharide-induced atherosclerosis development in apolipoprotein E-knockout mice.

artículo científico publicado en 2007

Blood pressure decrease in spontaneously hypertensive rats folowing renal denervation or dopamine β-hydroxylase inhibition with etamicastat.

artículo científico publicado en 2015

Blood pressure-decreasing effect of etamicastat alone and in combination with antihypertensive drugs in the spontaneously hypertensive rat

artículo científico publicado en 2014

Carbamazepine aggravates absence seizures in two dedicated mouse models

artículo científico publicado en 2015

Carbamazepine and oxcarbazepine, but not eslicarbazepine, enhance excitatory synaptic transmission onto hippocampal CA1 pyramidal cells through an antagonist action at adenosine A1 receptors

artículo científico publicado en 2015

Cardiovascular safety pharmacology profile of etamicastat, a novel peripheral selective dopamine-β-hydroxylase inhibitor

artículo científico publicado en 2015

Characterization of the interaction of the novel antihypertensive etamicastat with human dopamine-β-hydroxylase: comparison with nepicastat.

artículo científico publicado en 2015

Discovery of a Potent, Long-Acting, and CNS-Active Inhibitor (BIA 10-2474) of Fatty Acid Amide Hydrolase

artículo científico publicado en 2018

Drug-eluting stents: results, promises and problems.

artículo científico publicado en 2005

Early systemic inflammatory response to drug-eluting stents implantation: the heart of the difference? Editorial to: "Comparison of changes in early inflammatory markers between sirolimus- and paclitaxel-eluting stent implantation" by Li et al.

artículo científico publicado en 2008

Eslicarbazepine acetate for the treatment of focal epilepsy: an update on its proposed mechanisms of action

artículo científico publicado en 2015

Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: a comparison with carbamazepine, oxcarbazepine and lacosamide.

artículo científico publicado en 2014

Genetic Inflammatory Factors Predict Restenosis After Percutaneous Coronary Interventions

article

Histopathologic alterations following local delivery of dexamethasone to inhibit restenosis in murine arteries

artículo científico publicado en 2005

Increased arterial blood pressure and vascular remodeling in mice lacking salt-inducible kinase 1 (SIK1).

artículo científico publicado en 2015

Inhibition of neointima formation by local delivery of estrogen receptor alpha and beta specific agonists

artículo científico publicado en 2006

Lack of salt-inducible kinase 2 (SIK2) prevents the development of cardiac hypertrophy in response to chronic high-salt intake.

artículo científico publicado en 2014

Lipoprotein Lipase Gene Polymorphisms and the Risk of Target Vessel Revascularization After Percutaneous Coronary Intervention

article

Local perivascular delivery of anti-restenotic agents from a drug-eluting poly(epsilon-caprolactone) stent cuff

artículo científico publicado en 2005

Preclinical pharmacological evaluation of the fatty acid amide hydrolase inhibitor BIA 10-2474

artículo científico publicado en 2020

Role of P-glycoprotein and permeability upon the brain distribution and pharmacodynamics of etamicastat: a comparison with nepicastat.

artículo científico publicado en 2015

Short-term dexamethasone treatment inhibits vein graft thickening in hypercholesterolemic ApoE3Leiden transgenic mice

artículo científico publicado en 2006

Sirolimus and paclitaxel provoke different vascular pathological responses after local delivery in a murine model for restenosis on underlying atherosclerotic arteries.

artículo científico publicado en 2007

Targeting pharmacoresistant epilepsy and epileptogenesis with a dual-purpose antiepileptic drug

artículo científico publicado en 2014

The effect of interleukin-10 knock-out and overexpression on neointima formation in hypercholesterolemic APOE*3-Leiden mice

The influence of established genetic variation in the haemostatic system on clinical restenosis after percutaneous coronary interventions

Tumor necrosis factor-alpha plays an important role in restenosis development

artículo científico publicado en 2005

Vitamin D receptor: a new risk marker for clinical restenosis after percutaneous coronary intervention

artículo científico publicado en 2010

Lista de obras de Nuno Miguel Pires

Activation of nuclear receptor Nur77 by 6-mercaptopurine protects against neointima formation.

Apolipoprotein C-I is crucially involved in lipopolysaccharide-induced atherosclerosis development in apolipoprotein E-knockout mice.

Blood pressure decrease in spontaneously hypertensive rats folowing renal denervation or dopamine β-hydroxylase inhibition with etamicastat.

Blood pressure-decreasing effect of etamicastat alone and in combination with antihypertensive drugs in the spontaneously hypertensive rat

Carbamazepine aggravates absence seizures in two dedicated mouse models

Carbamazepine and oxcarbazepine, but not eslicarbazepine, enhance excitatory synaptic transmission onto hippocampal CA1 pyramidal cells through an antagonist action at adenosine A1 receptors

Cardiovascular safety pharmacology profile of etamicastat, a novel peripheral selective dopamine-β-hydroxylase inhibitor

Characterization of the interaction of the novel antihypertensive etamicastat with human dopamine-β-hydroxylase: comparison with nepicastat.

Discovery of a Potent, Long-Acting, and CNS-Active Inhibitor (BIA 10-2474) of Fatty Acid Amide Hydrolase

Drug-eluting stents: results, promises and problems.

Early systemic inflammatory response to drug-eluting stents implantation: the heart of the difference? Editorial to: "Comparison of changes in early inflammatory markers between sirolimus- and paclitaxel-eluting stent implantation" by Li et al.

Eslicarbazepine acetate for the treatment of focal epilepsy: an update on its proposed mechanisms of action

Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: a comparison with carbamazepine, oxcarbazepine and lacosamide.

Genetic Inflammatory Factors Predict Restenosis After Percutaneous Coronary Interventions

Histopathologic alterations following local delivery of dexamethasone to inhibit restenosis in murine arteries

Increased arterial blood pressure and vascular remodeling in mice lacking salt-inducible kinase 1 (SIK1).

Inhibition of neointima formation by local delivery of estrogen receptor alpha and beta specific agonists

Lack of salt-inducible kinase 2 (SIK2) prevents the development of cardiac hypertrophy in response to chronic high-salt intake.

Lipoprotein Lipase Gene Polymorphisms and the Risk of Target Vessel Revascularization After Percutaneous Coronary Intervention

Local perivascular delivery of anti-restenotic agents from a drug-eluting poly(epsilon-caprolactone) stent cuff

Preclinical pharmacological evaluation of the fatty acid amide hydrolase inhibitor BIA 10-2474

Role of P-glycoprotein and permeability upon the brain distribution and pharmacodynamics of etamicastat: a comparison with nepicastat.

Short-term dexamethasone treatment inhibits vein graft thickening in hypercholesterolemic ApoE3Leiden transgenic mice

Sirolimus and paclitaxel provoke different vascular pathological responses after local delivery in a murine model for restenosis on underlying atherosclerotic arteries.

Targeting pharmacoresistant epilepsy and epileptogenesis with a dual-purpose antiepileptic drug

The effect of interleukin-10 knock-out and overexpression on neointima formation in hypercholesterolemic APOE*3-Leiden mice

The influence of established genetic variation in the haemostatic system on clinical restenosis after percutaneous coronary interventions

Tumor necrosis factor-alpha plays an important role in restenosis development

Vitamin D receptor: a new risk marker for clinical restenosis after percutaneous coronary intervention